Mesenchymal stem cells (MSC) exhibit a high self‐renewal capacity, multilineage
differentiation potential and immunomodulatory properties. This set of exceptional features …

Mesenchymal stem cell (MSC) research progressively moves towards clinical phases.
Accordingly, a wide range of different procedures were presented in the literature for MSC …

Around 5 million annual births in EU and 131 million worldwide give a unique opportunity to
collect lifesaving Wharton's jelly derived mesenchymal stem cells (WJ‐MSC). Evidences that …

Mesenchymal stem cells (MSC) comprise a heterogeneous population of rapidly
proliferating cells that can be isolated from adult (eg, bone marrow, adipose tissue) as well …

Stem cell therapies offer a great promise for regenerative and reconstructive medicine, due
to their self-renewal and differentiation capacity. Although embryonic stem cells are …

Human umbilical cord mesenchymal stem cells (hUCMSCs) are considered to be an ideal
replacement for bone marrow MSCs. However, up to date, there is no convenient and …

Abstract Type 2 diabetes (T2D) is characterized by progressive and inexorable β‑cell
dysfunction, leading to insulin deficiency. Novel strategies to preserve the remaining β‑cells …

AIM: To explore the feasibility of placenta tissue as a reliable and efficient source for
generating mesenchymal stem cells (MSC). METHODS: MSC were generated from human …

Nearly 1.5 million people in the US live with a spinal cord injury (SCI). The cost to the
healthcare system is estimated at over $10 billion annually likely because over 65% of SCIs …

Mesenchymal stem/progenitor cells (MSCs) are key players in regenerative medicine,
relying principally on their differentiation/regeneration potential, immunomodulatory …